We are excited to introduce Prof. Amrita Pande as speaker at our conference on Reproductive Rights: Legal Developments and Challenges.

We are excited to introduce Prof. Michele Goodwin as speaker at our conference on Reproductive Rights: Legal Developments and Challenges. She will be introducing the session on Abortion Care on, 15 May 2024.

We are excited to introduce Prof. Jennifer Merchant as a speaker at our conference on Reproductive Rights: Legal Developments and Challenges. She will be introducing the session on Reproductive Technologies, 15 may 2024.

Newest publication by Anniek de Ruijter from the Law Centre for Health and Life, together with Francesco Nicoli, David van der Duin, Roel Beetsma, Brörn Bremer, Brian Brugoon, Theresa Kuhn and Maurits J. Meijers.

The Law Centre for Health and Life is submitting a workshop proposal to the 9th conference of the European Association of Health Law. This conference will be held at Warsaw University, Poland from 18-20 September 2024.

We are delighted to welcome Jannet Vaessen as a Senior Research Fellow at the Law Centre for Health and Life.

In the Dutch Journal of Health Law, Corrette Ploem and Merel Spaander, of the Law Centre for Health and Life, wrote more about the legal framework for the postmortem use of embryos in the Netherlands.

What new developments and solution pathways can enhance access to medicines, vaccines and health products? LCHL’s Katrina Perehudoff spoke about these issues in her oral intervention at the OHCRH’s second Expert Workshop

The Law Centre for Health and Life is delighted to invite abstract submissions for the 2024 conference on Reproductive Rights: Legal developments and challenges, to be held at the Limmikhof in Amsterdam on 15 and 16 May

Mahsa Shabani together with Ciara Staunton, Deborah Mascalzoni, Signe Mežinska & Santa Slokenberga published an article in the European Journal of Human Genetics.

On Monday, February 12, 2024, Corrette Ploem appeared on the Dutch news broadcaster NOS to share her expertise on the current problems in reimbursing breast reconstruction by health insurers.

What regulation, incentives, and governance structures can motivate the private sector to fairly price its medicines? Katrina Perehudoff was invited to speak about this issue at a plenary session for the 4th WHO Forum.